Translational approach from preclinical to clinical: comparison of dose finding methods of a new Bcl2 inhibitor using PK-PD modeling and interspecies extrapolation.
Invest New Drugs
; 38(6): 1796-1806, 2020 12.
Article
in En
| MEDLINE
| ID: mdl-32451663
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Proto-Oncogene Proteins c-bcl-2
/
Models, Biological
/
Neoplasms
/
Antineoplastic Agents
Type of study:
Diagnostic_studies
/
Prognostic_studies
Limits:
Animals
/
Female
/
Humans
Language:
En
Journal:
Invest New Drugs
Year:
2020
Document type:
Article
Affiliation country:
Francia
Country of publication:
Estados Unidos